Ellevest Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $752K | Buy |
1,534
+92
| +6% | +$40.8K | 0.09% | 167 |
|
|
2026
Q1 | $644K | Buy |
1,442
+561
| +64% | +$262K | 0.09% | 164 |
|
|
2025
Q4 | $399K | Sell |
881
-18
| -2% | -$7.76K | 0.06% | 267 |
|
|
2025
Q3 | $352K | Buy |
899
+22
| +3% | +$9.19K | 0.05% | 297 |
|
|
2025
Q2 | $390K | Sell |
877
-231
| -21% | -$106K | 0.06% | 251 |
|
|
2025
Q1 | $537K | Sell |
1,108
-546
| -33% | -$254K | 0.04% | 179 |
|
|
2024
Q4 | $666K | Sell |
1,654
-107
| -6% | -$49.6K | 0.04% | 151 |
|
|
2024
Q3 | $819K | Buy |
1,761
+14
| +0.8% | +$6.72K | 0.05% | 132 |
|
|
2024
Q2 | $819K | Buy |
1,747
+65
| +4% | +$28.2K | 0.05% | 123 |
|
|
2024
Q1 | $703K | Sell |
1,682
-7
| -0.4% | -$2.96K | 0.04% | 146 |
|
|
2023
Q4 | $687K | Sell |
1,689
-121
| -7% | -$44.7K | 0.05% | 130 |
|
|
2023
Q3 | $629K | Buy |
1,810
+232
| +15% | +$81.1K | 0.05% | 120 |
|
|
2023
Q2 | $555K | Buy |
1,578
+117
| +8% | +$39.4K | 0.04% | 136 |
|
|
2023
Q1 | $460K | Buy |
1,461
+265
| +22% | +$79.5K | 0.04% | 151 |
|
|
2022
Q4 | $345K | Buy |
1,196
+103
| +9% | +$31.4K | 0.03% | 206 |
|
|
2022
Q3 | $316K | Buy |
1,093
+235
| +27% | +$67.6K | 0.03% | 173 |
|
|
2022
Q2 | $242K | Buy |
858
+645
| +303% | +$173K | 0.02% | 245 |
|
|
2022
Q1 | $56K | Sell |
213
-41
| -16% | -$9.73K | ﹤0.01% | 505 |
|
|
2021
Q4 | $56K | Sell |
254
-1,132
| -82% | -$220K | 0.01% | 489 |
|
|
2021
Q3 | $251K | Sell |
1,386
-71
| -5% | -$13.9K | 0.02% | 232 |
|
|
2021
Q2 | $294K | Buy |
1,457
+271
| +23% | +$56.7K | 0.03% | 177 |
|
|
2021
Q1 | $255K | Buy |
1,186
+215
| +22% | +$47.2K | 0.03% | 163 |
|
|
2020
Q4 | $229K | Buy |
971
+171
| +21% | +$39.2K | 0.03% | 137 |
|
|
2020
Q3 | $218K | Buy |
800
+161
| +25% | +$44.4K | 0.04% | 124 |
|
|
2020
Q2 | $186K | Buy |
639
+307
| +92% | +$83.2K | 0.04% | 121 |
|
|
2020
Q1 | $79K | Buy |
332
+111
| +50% | +$25.5K | 0.02% | 166 |
|
|
2019
Q4 | $48K | Buy |
221
+200
| +952% | +$40.5K | 0.01% | 205 |
|
|
2019
Q3 | $4K | Sell |
21
-10
| -32% | -$1.77K | ﹤0.01% | 287 |
|
|
2019
Q2 | $6K | Buy |
31
+11
| +55% | +$1.92K | ﹤0.01% | 292 |
|
|
2019
Q1 | $4K | Hold |
20
| – | – | ﹤0.01% | 257 |
|
|
2018
Q4 | $3K | Buy |
+20
| New | +$3.46K | ﹤0.01% | 457 |
|
Other funds holding VRTX
Ellevest Inc's VRTX Position: Q2 2026 in Review
Ellevest Inc increased its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q2 2026, buying an estimated $40.8K and bringing the position to 1,534 shares worth $752K. The position accounts for 0.09% of the portfolio, ranked #167.
Ellevest Inc first reported a position in VRTX in Q4 2018 and has held it in 31 quarters since. The position peaked at $819K in Q3 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ellevest Inc held 1,534 shares of Vertex Pharmaceuticals worth $752K as of Q2 2026.
- Ellevest Inc bought 92 Vertex Pharmaceuticals shares in Q2 2026, an estimated $40.8K.
- Vertex Pharmaceuticals made up 0.09% of Ellevest Inc's portfolio in Q2 2026, its #167 holding.
- Ellevest Inc first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
- Ellevest Inc's Vertex Pharmaceuticals position peaked at $819K in Q3 2024.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.